Details for New Drug Application (NDA): 204025
✉ Email this page to a colleague
The generic ingredient in FOSAPREPITANT DIMEGLUMINE is fosaprepitant dimeglumine. There are eleven drug master file entries for this compound. Twenty-four suppliers are listed for this compound. Additional details are available on the fosaprepitant dimeglumine profile page.
Summary for 204025
Tradename: | FOSAPREPITANT DIMEGLUMINE |
Applicant: | Accord Hlthcare |
Ingredient: | fosaprepitant dimeglumine |
Patents: | 0 |
Suppliers and Packaging for NDA: 204025
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
FOSAPREPITANT DIMEGLUMINE | fosaprepitant dimeglumine | POWDER;INTRAVENOUS | 204025 | ANDA | Accord Healthcare Inc. | 16729-240 | 16729-240-03 | 1 VIAL, SINGLE-DOSE in 1 CARTON (16729-240-03) / 5 mL in 1 VIAL, SINGLE-DOSE |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | POWDER;INTRAVENOUS | Strength | EQ 150MG BASE/VIAL | ||||
Approval Date: | Aug 26, 2020 | TE: | AP | RLD: | No |
Complete Access Available with Subscription